For comments, suggestions
Created with Raphaël 2.1.0 23.05.2022 Filing date 07.10.2022 Validation fee payment 28.02.2023 (A1) Patent application published 04.10.2023 AGEPI application filing date 31.01.2024 (T2) Translation of the validated European patent 27.04.2025 23.05.2025 Valid until 24.05.2026 Renewal fee to be paid until 23.05.2042 Patent will expire on

Patent in force


(210)Number of the EPO application22731960
(220)Filing date of the EPO application2022.05.23
(80)EPO patent specification publication (B)EPB nr. 29/2023, 2023.07.19
(110)EPO patent number4114404
(11)Number of the documentMD 4114404 T2
(21)Number of the applicatione 2023 0065
(71)Name(s) of applicant(s), code of the countryMEDICON PHARMACEUTICALS, INC., US;
(72)Name(s) of inventor(s), code of the countryRIGAS Basil, US;
(73)Name(s) of owner(s), code of the countryMEDICON PHARMACEUTICALS, INC., US;
(54)Title of the inventionTreating pain associated with diabetic peripheral neuropathy
(13)Kind-of-document code T2
(51)International Patent Classification A61K 31/661 (2006.01.01); A61P 25/02 (2006.01.01)
(19)CountryUS
(41)Date of publication of the application2023.02.28
(49)Date of publication of the translation of the validated European patent specification2024.01.31
(30)Priority202163192248 P, 2021.05.24, US
(74)Patent attorney(Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova
(86)International applicationPCT/US2022/072497, 2022.05.23
(87)International publicationWO 2022/251806, 2022.12.01
Up
/Inventions/details/4114404